Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of **folic acid** (synthetic, oxidized form of folate) and **5-methyltetrahydrofolate (5-MTHF)** (the primary natural, bioactive form of folate in circulation). Both are B9 vitamers involved in one-carbon metabolism crucial for DNA synthesis, methylation, and amino acid metabolism. Folic acid requires metabolic reduction by dihydrofolate reductase to become biologically active, whereas 5-MTHF is directly bioavailable and bypasses genetic and functional limitations of folic acid metabolism[1][5]. This combination is used in dietary supplements, especially prenatal vitamins, to ensure adequate folate levels in populations with potentially variable folic acid metabolism due to MTHFR polymorphisms, or in settings where maximizing serum folate (especially 5-MTHF) is desired to prevent neural tube defects, correct deficiency, and support overall methylation pathways[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on folic acid + 5-methyltetrahydrofolate.